Comparison of industry innovation system between communicationequipment sector and pharmaceutical sector in China

Abstract

Abstract: Communication equipment and pharmaceutical are two key high-tech sectors supported by Chinese government during their development. There are obvious differences in the innovation between these two sectors. Nowadays, communication equipment sector has stronger ability to innovate than the pharmaceutical sector has in China. Using industrial innovation system framework, the innovation gap between these two sectors is explained. The differences in the knowledge base, the behavior individual and network, and the institution base between these two sectors explain why communication equipment sector has higher innovative capability than pharmaceutical sector has to a certain degree.

Key words: industrial innovation system, communication equipment sector, pharmaceutical sector, comparison

CLC Number:

F270.3
F426

Ren Shengce. Comparison of industry innovation system between communicationequipment sector and pharmaceutical sector in China[J]. Science Research Management, 2013, (4): 34-42.

References

[1] Michael J. Dowling and Timothy W. Ruefli. Technological innovation as a gateway to entry: The case of the telecommunications equipment industry[J]. Research Policy.Volume 21, Issue 1, February 1992, Pages 63-77.
[2] Helge Godoe.Innovation regimes, R&D and radical innovations in telecommunications [J]. Research Policy.Volume 29, Issue 9, December 2000, Pages 1033-1046.
[3] LIU, Xielin, Path-following or Leapfrogging in Catching-up: the Case of Chinese Telecommunication Equipment Industry. [EB/OL].CIRCLE Electronic Working Paper Series, Paper no. 2007/01.
[4] Jiang Yu. From path-following to path-creating, some paradigm shifts in China’s catching-up[J].International Journal of Technology and Globalisation. Issue: Volume 3, Number 4/2007.p.409-421.
[5] Peilei Fan. Catching up through developing innovation capability: evidence from China’s telecom-equipment industry [J]. Technovation.Volume 26, Issue 3, March 2006, Pages 359-368.
[6] Prentis, RA, Lis, Y. and Walker, SR. Pharmaceutical innovation by the seven U.K.-owned pharmaceutical companies (1964-1985) [J]. Br J Clin Pharmacol. 1988 Mar; 25(3):387-96
[7] Basil Achilladelis, Nicholas Antonakis.The dynamics of technological innovation: the case of the pharmaceutical industry [J]. Research Policy 30(2001).535-588
[8] 佟石.基于价值网络的我国医药企业创新集成管理研究, 2004复旦大学博士论文.
[9] Daron Acemoglu, Joshua Linn.Market Size in Innovation: Theory and Evidence from the Pharmaceutical Industry [J].The Quarterly Journal of Economics. 119 (2004) 3 (August): 1049-1090
[10] E González. Sources of productivity growth in the Spanish pharmaceutical industry (1994-2000) [J].Research Policy, Volume 33, Issue 5, July 2004, Pages 735-745
[11] Bernard Munos.Lessons from 60 years of pharmaceutical innovation [J].Nature Reviews Drug Discovery, Vol. 8, No. 12. (01 December 2009), pp. 959-968
[12] A Hashimoto, S Haneda. Measuring the change in R&D efficiency of the Japanese pharmaceutical industry [J].Research Policy, Volume 37, Issue 10, 2008: 1829-1836
[13] Garnier JP. Rebuilding the R&D engine in big pharma [J]. Harvard Bus. Rev. 86, 68-76 (2008).
[14] Henderson R.,Cockburn I., Measuring Competence? Exploring Firm Effects in Pharmaceutical Research [J], Strategeic Management Journal,1995(winter),15:63-84
[15] Steven Casper,Catherine Matraves, Institutional frameworks and innovation in the German and UK pharmaceutical industry [J], Research Policy,2003,32:1865-1879
[16] 柳卸林著.全球化、追赶与创新[M],科学出版社,北京:2008.
[17] Franco Malerba and Sunil Mani, Sectoral systems of Innovation and Production in Developing Countries [M], Edward Elgar. UK.2009
[18] Nelson, R. R., & Winter, S. G.. An evolutionary theory of economic change [M]. Cambridge, Mass.: Belknap Press of Harvard University Press.
[19] Breschi, S., F. Malerba and L. Orsenigo, Technological regimes and Schumpeterian patterns of innovation[J], Economic Journal, 110(463), 388-410.
[20] FRANCO MALERBA. Sectoral systems of innovation: how and why innovation differs across sectors in Handbook of Innovation[M]. J. Fagerber, D. Mowery and R. Nelson (ed). Cambridge University Press, Cambridge 2004.(中文版:詹法格博格,戴维莫利,理查德纳而逊.主编,牛津创新手册,柳卸林等译,知识产权出版社,2009.)
[21] Pavitt,K. Sectoral patterns of technical change:towards a taxonomy and a theory[J]. Research Policy, (1984)13,343-73
[22] Kyoo-Ho Park and Keun Lee,Linking the technological regime to the technological catch-up: analyzing Korea and Taiwan using the US patent data[J],Industrial and Corporate Change, (2006)Volume 15, No. 4:715-753
[23] Keun Lee, Chaisung Lim,Technological regimes, catching-up and leapfrogging: findings from the Korean industries[J], Research Policy, (2001)30:459-483
[24] Poel, I. v. d. The transformation of technological regimes[J]. Research policy. (2003)32:49-68.
[25] Mu, Q.,Lee, K., 2005. Knowledge diffusion, market segmentation and technological catching-up: the case of the telecommunication industry in China [J], Research Policy, 34(2005), 759-783.
[26] Fulvio Castellacci (2008),Technological paradigms, regimes and trajectories: Manufacturing and service industries in a new taxonomy of sectoral patterns of innovation[J], Research Policy 37:978-994
[27] 唐春晖,唐要家.技术模式与中国产业技术追赶[J],中国软科学,2006(4):59-65.
[28] Pisano GP. Pharmaceutical Biotechnology, In Technological Innovation and Economic Performance [M].B, Steil D. Victor and Nelson R. Princeton: Princeton University Press,2002.
[29] 曲凤宏,黄泰康. 简述我国国家药物创新体系的历史演进[J].中国药物, 2006,15 (2): 18-19.
[30] Shulin GU, Bengt-Aake Lundvall, Ju LIU, Franco Malerba & Sylvia Schwaag Serger: China’s System and Vision of Innovation: An Analysis in Relation to the Strategic Adjustment and the Medium- to Long-Term S&T Development Plan (2006-20) [J].Industry and Innovation (I&I), Vol. 16, No. 4, 369-388, August 2009.
[31] Jensen, M. B., Johnson, B., Lorenz, E. and Lundvall, B.-A°. Forms of knowledge and modes of innovation [J], Research Policy, (2007) 36(5),pp. 680-693.